NIMMY TREEZA
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health EATONTOWN, NJ NPI 1033657259
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health NJ Daiichi Sankyo Inc. All categories
General Payments — all program years on this page
$4,850.40
- Category: General Payments
- Program years: PY2021–2024
- Record count: 270
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,171.10 across 64 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,154.08 | 63 |
| Education | $17.02 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $233.28 | 12 |
| ABBVIE INC. | $108.87 | 7 |
| Merck Sharp & Dohme Corporation | $92.77 | 5 |
| Incyte Corporation | $72.10 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $62.46 | 3 |
| Pharmacosmos Therapeutics Inc. | $57.74 | 3 |
| GlaxoSmithKline, LLC. | $50.94 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $47.54 | 2 |
| Myriad Genetic Laboratories, Inc. | $42.87 | 2 |
| Tempus AI, Inc | $38.50 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $35.93 | 2 |
| EISAI INC. | $34.53 | 2 |
| Gilead Sciences, Inc. | $33.06 | 2 |
| Genmab U.S., Inc. | $24.58 | 1 |
| Rigel Pharmaceuticals, Inc. | $20.47 | 1 |
| Genentech USA, Inc. | $19.83 | 1 |
| SOBI, INC | $18.89 | 1 |
| Kyowa Kirin, Inc. | $18.29 | 1 |
| Karyopharm Therapeutics Inc. | $17.85 | 1 |
| Regeneron Healthcare Solutions, Inc. | $17.02 | 1 |
| PFIZER INC. | $16.74 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $16.52 | 1 |
| Acrotech Biopharma Inc. | $16.34 | 1 |
| JAZZ PHARMACEUTICALS INC. | $16.18 | 1 |
| Octapharma USA, Inc. | $15.13 | 1 |
| Deciphera Pharmaceuticals Inc. | $14.82 | 1 |
| E.R. Squibb & Sons, L.L.C. | $13.99 | 1 |
| Lilly USA, LLC | $13.86 | 1 |
By program year
Records — PY2024 (64)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.